Key result
Spinal cord transcutaneous stimulation improves peak inspiratory and expiratory flow in post-acute COVID-19.
Why the study?
COVID-19 is associated with respiratory and central nervous system dysfunctions, and the effects of spinal cord transcutaneous stimulation on respiratory function in post-COVID-19 patients were not established.
Does transcutaneous spinal cord stimulation improve respiratory functional performance in patients with post-acute COVID-19 respiratory deficits?
Case-Control (n=18)
Does transcutaneous spinal cord stimulation improve respiratory functional performance in patients with post-acute COVID-19 respiratory deficits?
A single session of transcutaneous spinal cord stimulation immediately improved inspiratory and expiratory functional performance in patients with post-acute COVID-19 respiratory deficits.
Answers are grounded in this paper and cite their sources.
scTS may aid post-acute COVID respiratory function; hypothesis-generating and should not change practice pending RCTs.
Background: A growing number of studies have reported Coronavirus disease (COVID-19)-related to both respiratory and central nervous system dysfunctions. This study evaluates the neuromodulatory effects of spinal cord transcutaneous stimulation (scTS) on the respiratory functional state in healthy controls and patients with post-COVID-19 respiratory deficits as a step toward the development of a rehabilitation strategy for these patients.; Methods: In this before-after, interventional, case-controlled clinical study, ten individuals with post-acute COVID-19 respiratory deficits and eight healthy controls received a single twenty-minute-long session of modulated monophasic scTS delivered over the T5 and T10 spinal cord segments. Forced Vital Capacity (FVC), Peak Forced Inspiratory Flow (PIF), Peak Expiratory Flow (PEF), Time-To-Peak of Inspiratory Flow (tPIF), and Time-To-Peak of Expiratory Flow (tPEF) were assessed before and after the intervention; Results: In COVID-19 group, the scTS intervention led to significantly increased PIF (p= .040) and PEF (p= .049) in association with significantly decreased tPIF (p= .035) and tPEF (p= .013). In the Control Group, the exposure to scTS also resulted in significantly increased PIF (p= .010) and significantly decreased tPIF (p= .031). Unlike the results in COVID-19 group, there was significantly decreased PEF (p= .028) in association with significantly increased tPEF (p= .036). There were no changes for FVC after scTS in both groups (p= .67 and p= .503); Conclusions: In post-COVID-19 patients scTS facilitates excitation of both inspiratory and expiratory spinal neural networks leading to an immediate improvement of respiratory functional performance. This neuromodulation approach could be utilized in rehabilitation programs for patients with COVID-19 respiratory deficits.
No takes yet. Share an insight, caveat, or question.
Ovechkin et al. (2023) conducted a case-control in post-acute COVID-19 respiratory deficits (n=18). spinal cord transcutaneous stimulation (scTS) vs. Healthy controls was evaluated on Forced Vital Capacity (FVC), Peak Forced Inspiratory Flow (PIF), Peak Expiratory Flow (PEF), Time-To-Peak of Inspiratory Flow (tPIF), and Time-To-Peak of Expiratory Flow (tPEF) (p=0.040 for PIF, 0.049 for PEF). Spinal cord transcutaneous stimulation increased Peak Forced Inspiratory Flow and Peak Expiratory Flow in patients with post-acute COVID-19 respiratory deficits.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: